Bioniz therapeutics
WebMay 17, 2024 · Bioniz is building a pipeline of novel peptide therapeutics which selectively inhibit functionally redundant cytokines, while leaving the rest of the cytokine network unaffected. The company's lead product is BNZ-1, which targets cutaneous T-cell lymphoma and alopecia areata by simultaneously inhibiting cytokines IL-2, IL-9 and IL-15. WebNov 25, 2024 · Among these is the immune modulator BNZ-1 from Bioniz Therapeutics Inc.....cells and CD8+ central memory T cells while leaving other major immune cell …
Bioniz therapeutics
Did you know?
WebJul 31, 2024 · May 24, 2024 updated by: Bioniz Therapeutics. A Dose-Ranging Study of Intravenous BNZ132-1-40 in Patients With Large Granular Lymphocyte Leukemia or Refractory Cutaneous T-Cell Lymphoma. This study is an open-label, multi-center, dose-ranging study to characterize the safety, tolerability, preliminary efficacy, and PK/PD of … WebBioniz is a biopharmaceutical company leading the discovery and development of multiple-cytokine inhibitory therapeutics to address immuno-inflammatory diseases and cancer, …
WebFeb 16, 2024 · Equillium to host a conference call and webcast today at 8:00 a.m. Eastern Time. Equillium, Inc. EQ, a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe ... WebMar 7, 2024 · Bioniz Therapeutics / Almirall has leveraged its proprietary multi-cytokine inhibitor platform technology to develop BNZ-1 for an immuno-dermatology franchise in vitiligo, cutaneous T-cell lymphoma and alopecia areata. Multi-cytokine inhibitor is selectively targeting three interleukins, IL-2, IL-9, and IL-15. ...
WebJan 9, 2024 · About Bioniz Therapeutics . Bioniz Therapeutics is a clinical-stage biopharmaceutical company leading the discovery and development of first-in-class multi-cytokine inhibitory peptide therapeutics to address immuno-inflammatory diseases and cancer. Bioniz leverages its world-class expertise in cytokine biology, originated in … WebBioniz Therapeutics has raised a total of $14.3M in funding over 3 rounds. Their latest funding was raised on Aug 1, 2016 from a Series A round. Bioniz Therapeutics is funded by 4 investors. Takeda Ventures and Signatures Capital are the most recent investors.
WebEquillium, Inc., a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced ...
WebJul 20, 2024 · IRVINE, Calif., July 20, 2024 /PRNewswire/ -- Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company developing first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and cancers, today announced encouraging interim clinical data from its Phase … tennis courts in eagle idahoWebMar 24, 2024 · Bioniz Therapeutics is a clinical-stage biopharmaceutical company advancing a pipeline of first-in-class peptide-based multi-cytokine inhibitors for the … tennis courts in dallasWebBioniz Therapeutics has raised a total of $14.3M in funding over 3 rounds. Their latest funding was raised on Aug 1, 2016 from a Series A round. Bioniz Therapeutics is … tennis courts indoor near meWeb3 Bioniz Therapeutics, Inc., Irvine, California. 4 Department of Medicine, University of Chicago, Chicago, Illinois; Committee on Immunology, University of Chicago, Chicago, Illinois. 5 Department of Translational Medical Science and European Laboratory for the Investigation of Food Induced Diseases (ELFID), Università degli Studi di Napoli ... tennis courts in hot springs arWebJan 9, 2024 · Bioniz Therapeutics is a clinical-stage biopharmaceutical company leading the discovery and development of first-in-class multi-cytokine inhibitory peptide … tennis courts in elk grove caLA JOLLA, Calif.--(BUSINESS WIRE)-- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it has acquired Bioniz Therapeutics, Inc., a privately held clinical-stage biotechnology company. . Bioniz developed its novel structured-domain ... tennis courts in austinWebFeb 16, 2024 · Equillium (NASDAQ:EQ) acquired Bioniz Therapeutics, granting EQ exclusive worldwide rights to all current and future Bioniz products.; The consideration is comprised of an all-stock upfront ... tennis courts in makati